에 대한 최신 뉴스 Doximity (NYSE:DOCS) 주식

Doximity

Doximity Inc is a digital platform for U.S. medical professionals. Its cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers.

Large Cap

News

Movers

Trading Ideas

BIRK

CHWY

DOCS

KVYO

NBIX

TEVA

이들 10개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요? 1. 테바 파마수티컬스(NYSE:TEVA)의 주식은 회사와 사노피 SA(NASDAQ:SNY)가 궤양성 대장염 및 크론병에 대한 두바키투그(Duvakitug)의 2b상 시험에서 1차 평가변수가 충족되었다고 발표한 후 주가는 33.88% 상승했다.

테바, 리 오토 및 다덴 레스토랑이 지난주 최고 성과를 보여준 10개 대형주 중 일부 (12월 16-20일)

ALAB

AXON

COIN

HOOD

PLTR

RDDT

TSLA

이들 10개 대형주는 도널드 트럼프가 47대 대통령 선거에서 승리한 지난주에 가장 좋은 성과를 냈다. 1. 앱러빈(NASDAQ:APP)의 주식은 3분기 실적 발표 후 82.27% 급등했다. 여러 애널리스트들이 주가 전망을 상향 조정했다.

도널드 트럼프 승리 주(11월 4일-8일): 이들 10개 대형주는 가장 큰 폭의 상승 기록

Earnings

Guidance

Health Care

After-Hours Center

닥시미티(NYSE:DOCS)의 주식은 회사가 예상보다 좋은 2분기 재무 결과를 발표한 후 목요일 애프터 마켓 세션에서 37% 이상 급등했다. Q2 매출: 1억 3,683만 달러, 예상치 1억 2,715만 달러 대비 상회 Q2 조정 EPS: 30센트, 예상치 25센트 대비 상회

닥시미티의 주식은 강력한 2분기 실적을 발표한 후 시간외 거래에서 37% 이상 급등

Doximity Inc

BMO Capital analyst Jack Matten initiates coverage on Corebridge Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRBG#NYSE">CRBG</a>) with a Outperform rating and announces Price Target of $43.

Price Target

Initiation

Analyst Ratings

CRBG

BMO Capital Initiates Coverage On Corebridge Financial with Outperform Rating, Announces Price Target of $43

Sam Altman, CEO of OpenAI, has publicly expressed his support for President Donald Trump. This revelation comes years after he praised LinkedIn co-founder Reid Hoffman for stopping his re-election.
What Happened: Altman disclosed that his perspective on President Trump has evolved. He mentioned that observing the president more closely has shifted his views. Altman admitted to previously falling into what he termed the &#8220;npc trap,&#8221; suggesting a lack of personal critical thinking.
He added that although he does not agree with Trump on every issue, Altman believes the president will have a positive impact on the country. This shift in Altman&#8217;s stance is part of a larger trend where tech leaders are increasingly engaging with political figures.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">watching <a href="https://twitter.com/POTUS?ref_src=twsrc%5Etfw">@potus</a> more carefully recently has really changed my perspective on him (i wish i had done more of my own thinking and definitely fell in the npc trap). i&#39;m not going to agree with him on everything, but i think he will be incredible for the country in many ways!
&mdash; Sam Altman (@sama) <a href="https://twitter.com/sama/status/1882234406662000833?ref_src=twsrc%5Etfw">January 23, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
His comments arise amidst ongoing discussions about technology&#8217;s role in shaping public policy and governance.
Also See: <a href="https://www.benzinga.com/25/01/43152627/microsoft-ceo-satya-nadella-stands-firm-after-elon-musk-questions-stargates-100-billion-funding-potential-all-i-know-is-im-good-for-my-80-billion">Satya Nadella Stands Firm After Elon Musk Questions Stargate&#8217;s $100 Billion Funding Potential: &#8216;All I Know Is, I&#8217;m Good For My $80 Billion&#8217;</a>
"Very few people realize just how much @reidhoffman did and spent to stop Trump from getting re-elected&#8211;it seems reasonably likely to me that Trump would still be in office without his efforts. Thank you, Reid!"
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Very few people realize just how much <a href="https://twitter.com/reidhoffman?ref_src=twsrc%5Etfw">@reidhoffman</a> did and spent to stop Trump from getting re-elected&#8211;it seems reasonably likely to me that Trump would still be in office without his efforts. Thank you, Reid!
&mdash; Sam Altman (@sama) <a href="https://twitter.com/sama/status/1471210631969660930?ref_src=twsrc%5Etfw">December 15, 2021</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Altman&#8217;s comments come at a time when&nbsp;<a href="https://www.benzinga.com/24/12/42334927/sam-altman-brushes-off-elon-musks-trump-ties-but-admits-xai-is-a-serious-threat-to-openai-i-may-turn-out-to-be-wrong-but">political dynamics</a>&nbsp;in the tech industry are under scrutiny. In December, Altman expressed confidence that&nbsp;Elon Musk&nbsp;would not misuse his political influence, despite Musk&#8217;s ties with President Trump.
This was during a period when Altman acknowledged Musk&#8217;s xAI as a significant competitor to OpenAI.
<a href="https://www.benzinga.com/25/01/43111153/nvidia-and-ai-stock-rises-as-trump-announces-500-billion-stargate-ai-infrastructure-venture">Project Stargate</a>&nbsp;was announced earlier this week – it is a $500 billion AI infrastructure venture involving OpenAI, SoftBank Group (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>), and Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>). This initiative aims to establish the U.S. as a leader in AI technology.
However, Musk&nbsp;expressed skepticism about the project&#8217;s funding, suggesting that the lead investor, SoftBank, had secured less than $10 billion. Despite this, the venture has sparked interest in AI stocks, including NVIDIA and Oracle.
Check out more of Benzinga&#8217;s Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/tech/25/01/43073185/mark-zuckerberg-is-copying-elon-musks-playbook-amid-donald-trumps-comeback-but-chamath-palihapitiya-thinks-it-is-opportunistic">Mark Zuckerberg Is Copying Elon Musk&#8217;s Playbook Amid Donald Trump&#8217;s Comeback, But Chamath Palihapitiya Thinks It Is Opportunistic</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photos courtesy: Shutterstock

Politics

Tech

ORCL

SFTBY

OpenAI's Sam Altman Flip Flops On Trump After $500 Billion Stargate AI Project, Says 'I Wish I Had Done More Of My Own Thinking'

TikTok-parent ByteDance is reportedly gearing up to invest over $12 billion in artificial intelligence infrastructure by 2025.
What Happened: The Beijing-based tech giant has allocated approximately RMB 40 billion ($5.5 billion) for AI chip acquisitions within China, effectively doubling its expenditure from the previous year, <a href="https://www.ft.com/content/0815c8fb-e6ed-478b-abb1-c67d6f48fd3a">reported</a> the Financial Times, citing two people familiar with the plans.
ByteDance also plans to invest around $6.8 billion overseas to <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42725613/tiktok-parent-plans-7-billion-ai-push-with-nvidia-chips">improve its model training</a> capabilities using advanced Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) chips.
About 60% of ByteDance&#8217;s domestic semiconductor orders are expected to be fulfilled by Chinese suppliers like Huawei Technologies and Cambricon. The remaining orders will involve Nvidia chips modified to comply with U.S. export restrictions, the report noted.
See Also: <a href="https://www.benzinga.com/25/01/43151196/samsung-google-team-up-to-develop-ar-glasses-entering-the-race-against-meta-and-apple">Samsung, Google Team Up On AR Glasses Development, Duo To Enter Race Against Meta And Apple</a>
Why It Matters: This substantial investment is part of ByteDance&#8217;s strategy to expand its AI infrastructure and maintain its competitive edge in the AI sector.&nbsp;
However, it may encounter challenges due to U.S. export controls aimed at limiting Chinese access to sensitive technologies.
ByteDance is currently the <a href="https://www.benzinga.com/media/24/12/42382237/tiktok-parent-bytedance-now-nvidias-largest-asian-chip-customer-races-ahead-of-alibaba-and-baidu-to-dominate-chinas-generative-ai-market-report">largest buyer of Nvidia chips</a> in Asia, surpassing competitors such as Alibaba and Baidu.
The TikTok parent is restricted to purchasing less advanced chips like Nvidia&#8217;s H20, which are specifically designed with reduced capabilities to comply with U.S. export restrictions for Chinese data centers.
In 2024, ByteDance reportedly procured around 230,000 Nvidia chips, primarily H20 models, according to estimates from tech consultancy Omdia.
For comparison, Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) acquired approximately 485,000 of Nvidia&#8217;s more advanced "Hopper" chips during the same period, while Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) purchased 224,000.
ByteDance is also under significant pressure in its primary social media business. TikTok resumed operations for 170 million U.S. users on Sunday. On Monday, President Donald Trump issued an executive order allowing TikTok to remain operational for 75 days.
However, he underscored his expectation for a U.S. company to acquire a 50% ownership stake in the app and hinted at the possibility of imposing tariffs on China if a deal was not reached.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43152627/microsoft-ceo-satya-nadella-stands-firm-after-elon-musk-questions-stargates-100-billion-funding-potential-all-i-know-is-im-good-for-my-80-billion">Satya Nadella Stands Firm After Elon Musk Questions Stargate&#8217;s $100 Billion Funding Potential: &#8216;All I Know Is, I&#8217;m Good For My $80 Billion&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo courtesy: Shutterstock

Global

MSFT

NVDA

TikTok-Parent ByteDance Plans $12 Billion AI Chip Investment In 2025 To Bolster Global AI Ambitions Amid US Export Controls: Report

BMO Capital analyst Jack Matten initiates coverage on Prudential Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRU#NYSE">PRU</a>) with a Underperform rating and announces Price Target of $101.

BMO Capital Initiates Coverage On Prudential Financial with Underperform Rating, Announces Price Target of $101

Renowned investor Cathie Wood, CEO of Ark Invest believes President Donald Trump&#8217;s second administration could breathe new life into the struggling initial public offering landscape, potentially creating significant opportunities for investors and venture funds.
What Happened: In a recent Bloomberg ETF IQ interview, Wood highlighted the potential for regulatory changes that could dramatically transform public markets. &#8220;I hope regulatory changes will revive the public markets,&#8221; she <a href="https://www.bloomberg.com/news/videos/2025-01-22/cathie-wood-on-ark-etfs-ipos-m-a-tiktok-video">stated</a>, noting that the number of publicly traded companies has halved over the last two decades.
Wood&#8217;s ARK Investment Management sees particular promise in innovation-driven sectors, especially healthcare and artificial intelligence. 
She specifically pointed to her ARK Genomic Revolution ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>) as an underestimated investment, anticipating substantial changes in biotech and pharmaceutical <a href="https://www.benzinga.com/general/biotech/24/11/42206182/cathie-wood-sees-400b-opportunity-in-biologics-how-have-her-bets-fared">markets where $400 billion</a> in revenue is set to go off-patent within five years.
See Also: <a href="https://www.benzinga.com/news/25/01/43152917/elon-musk-led-doge-targets-us-penny-over-179m-annual-production-cost">Elon Musk&#8217;s DOGE Takes Aim At The US Penny Citing Soaring Production Costs</a>
Why It Matters: The investor expressed optimism about potential liquidity events that have been constrained during the previous administration. &#8220;We believe the IPO market will open up and give us opportunities to diversify our portfolios,&#8221; Wood said.
Specific sectors Wood highlighted include autonomous technology, with robotaxis representing a significant AI application, and healthcare transformation. She emphasized the potential for technological innovation, particularly in multi-omics and genomics spaces.
The potential market shifts come amid broader economic discussions. Former Treasury Secretary Larry Summers has warned about possible economic disruptions from proposed policies, suggesting <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42183404/cathie-wood-bets-on-thriving-ipo-market-under-trump-will-giveliquidity-events-that-they-have-not-enjoyed-during-the-last-four-years">significant macroeconomic implications</a> could accompany potential market changes.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43152627/microsoft-ceo-satya-nadella-stands-firm-after-elon-musk-questions-stargates-100-billion-funding-potential-all-i-know-is-im-good-for-my-80-billion">Satya Nadella Stands Firm After Elon Musk Questions Stargate&#8217;s $100 Billion Funding Potential: &#8216;All I Know Is, I&#8217;m Good For My $80 Billion&#8217;</a></li>
</ul>
Image via Benzinga YouTube and Unsplash
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Markets

ARKG

Cathie Wood Sees Trump's Second Term Reviving IPO Market, Unlocking Opportunities In Biotech And AI Sectors

BMO Capital analyst Jack Matten initiates coverage on Aflac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AFL#NYSE">AFL</a>) with a Market Perform rating and announces Price Target of $111.

BMO Capital Initiates Coverage On Aflac with Market Perform Rating, Announces Price Target of $111

BMO Capital analyst Jack Matten initiates coverage on Primerica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRI#NYSE">PRI</a>) with a Market Perform rating and announces Price Target of $311.

BMO Capital Initiates Coverage On Primerica with Market Perform Rating, Announces Price Target of $311

BMO Capital analyst Jack Matten initiates coverage on Unum Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNM#NYSE">UNM</a>) with a Outperform rating and announces Price Target of $91.

BMO Capital Initiates Coverage On Unum Gr with Outperform Rating, Announces Price Target of $91

Earnings Beats

TAL Education Q3 2025 Adj. EPADS $0.06 Beats $0.04 Estimate, Sales $606.446M Beat $542.189M Estimate

Cryptocurrency index fund manager Bitwise Asset Management filed for a Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) exchange-traded fund on Wednesday, prompting analysts to forecast big returns for the dog-themed meme coin.
What happened: Bitwise submitted the ETF <a href="https://icis.corp.delaware.gov/eCorp/EntitySearch/NameSearch.aspx?_=1737585406503">filing </a>to Delaware's Department of State's Division of Corporations. The filing was made under the entity name BITWISE DOGECOIN ETF, with CSC Delaware Trust Company listed as the registered agent.
While Bitwise didn't immediately return Benzinga's request to confirm the filing, leading ETF analyst Eric Balchunas said on X that the filing was legitimate.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Bitwise Doge ETF likely coming soon.. and yes I checked and this is def legit (vs some whack job committing forgery for a quick pump a la BlackRock XRP that one time). <a href="https://t.co/MxoswD0IFy">pic.twitter.com/MxoswD0IFy</a>
&mdash; Eric Balchunas (@EricBalchunas) <a href="https://twitter.com/EricBalchunas/status/1882202309293433217?ref_src=twsrc%5Etfw">January 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43151588/cathie-wood-was-asked-if-she-would-buy-trump-coin-heres-what-she-said">Cathie Wood Was Asked If She Would Buy TRUMP Coin, Here&#8217;s What She Said</a>
The Delaware registration is typically the first step in the ETF listing process and still requires an official filing with the SEC.&nbsp;
Similar listings were seen previously for iShares Bitcoin Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIT#NASDAQ">IBIT</a>) and iShares Ethereum Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETHA#NASDAQ">ETHA</a>), and even the <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41134111/after-bitcoin-ethereum-an-xrp-etf-bitwise-registers-filing-in-delaware-amid-rippe-vs-sec-l">XRP ETF</a> filed by Bitwise last year.
Following the filing, Ali Martinez, a well-known cryptocurrency analyst and trader, issued a massively bullish price target of $15 for Dogecoin. At the current price, this pointed to a staggering upside of 4140.88%
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> <a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> ETF will send it to $15! <a href="https://t.co/4peKi93NZX">https://t.co/4peKi93NZX</a> <a href="https://t.co/gRqDdoXhob">pic.twitter.com/gRqDdoXhob</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1882196406800445537?ref_src=twsrc%5Etfw">January 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: Bitwise&#8217;s registration comes after REXShares and Osprey filed numerous ETF applications with the SEC earlier this week, <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43105356/meme-coin-supercycle-dogecoin-trump-bonk-futures-etf-applications-filed">including one</a> for Dogecoin.
These filings were factored into prediction markets, as the odds of a Dogecoin ETF being approved in 2025 <a href="https://polymarket.com/event/doge-etf-approved-in-2025">increased </a>from 36% to 53% on Polymarket before stabilizing at 48% as of this writing.
Meanwhile, the iconic Shiba Inu imagery, a symbol closely tied to Dogecoin's popularity, <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43140690/dogecoin-drops-6-after-doge-department-removes-logo">was removed</a> from the Elon Musk-headed Department of Government Efficiency&#8217;s website.
Price Action: At the time of writing, Dogecoin was exchanging hands at $0.3535, down 3.07% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. Year-to-date, the cryptocurrency has gained 8.43%.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/01/43150952/blackrock-ceo-larry-fink-says-bitcoin-could-rise-to-700000-on-monetary-debasement-political-instability-fears">Blackrock CEO Larry Fink Says Bitcoin Could Rise To $700,000 On Fiat Fears: &#8216;If You&#8217;re Frightened Of The Debasement…&#8217;</a></li>
</ul>
Image via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

General

$DOGE

ETHA

IBIT

Bets Favoring Dogecoin ETF Approval In 2025 Jump After Bitwise's Delaware Filing—Top Trader Paints Over 4000% Upside For Memecoin

Elon Musk&#8216;s rocket manufacturing company SpaceX intends to put up a SpaceX Gigabay at Cape Canaveral in Florida by Aug. 2026, according to a new filing with the Federal Aviation Administration. 
What Happened: According to the filing, construction is planned to start in April this year and the vertical integration facility will be 380 feet tall and expected to handle the assembly and integration of SpaceX&#8217;s Starship launch vehicle.
All development and manufacturing of the Starship currently takes place at Starbase in Texas. All of the Starship's past test flights were launched from the commercial spaceport in Cameron County near the Gulf of Mexico.
However, in May, Musk took to social media and said the company aims to build two Starship towers at Cape Canaveral in Florida, hinting at plans to launch Starships from the state. While one of the two towers is expected to be at Kennedy Space Center Launch Complex 39A, the location for the second is still under consideration, the CEO said.
"We&#8217;re aiming to build two towers at the Cape for Starship, one at 39A and another tbd (we don&#8217;t have final approval yet)," Musk wrote.
Why It Matters:&nbsp;The Starship vehicle is part of big dreams. While NASA is looking forward to landing humans back on the surface of the Moon after a gap of over 50 years with the help of a&nbsp;<a href="https://www.benzinga.com/24/11/42108681/spacex-shows-off-conceptual-version-of-starship-which-will-help-humans-land-back-on-moon-in-over-50-yrs" target="_blank" rel="noreferrer noopener">custom version of Starship</a>, Musk is dreaming of taking&nbsp;<a href="https://www.benzinga.com/news/24/09/40770222/elon-musk-sets-2026-for-starships-first-uncrewed-mars-mission-targeting-successful-landing" target="_blank" rel="noreferrer noopener">humans to the planet Mars</a>&nbsp;aboard Starship.
&#8220;…I would not be surprised if we fly 400 Starship launches in the next four years," SpaceX President and COO&nbsp;Gwynne Shotwell&nbsp;<a href="https://www.benzinga.com/general/space/24/11/42105704/spacex-ceo-elon-musk-reveals-technical-glitch-that-led-company-to-drop-key-objective-of-starships-6th-test-flight" target="_blank" rel="noreferrer noopener">said at the Baron Investment Conference</a>&nbsp;in New York in November.
Starship is currently in the testing and development phase. The company has conducted seven test flights of the vehicle thus far starting in April 2023. The last flight test took place earlier this month.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/43152345/bmw-uk-exits-elon-musks-x-to-continue-posting-on-instagram-facebook">BMW UK Stops Posting On X, Will Use It Only For Customer Support: To Continue Posting On Instagram, Facebook</a></li>
</ul>
Photo courtesy: Shutterstock

SPACE

Elon Musk's SpaceX Plans Gigabay Facility In Florida For Starship Assembly

<h3>Companies Reporting Before The Bell</h3>
• Elevance Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) is estimated to report quarterly earnings at $3.86 per share on revenue of $44.72 billion. 
• Chunghwa Telecom (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHT#NYSE">CHT</a>) is projected to report earnings for its fourth quarter. 
• WNS (Hldgs) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNS#NYSE">WNS</a>) is likely to report quarterly earnings at $1.04 per share on revenue of $332.22 million. 
• Pacific Premier Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPBI#NASDAQ">PPBI</a>) is likely to report quarterly earnings at $0.31 per share on revenue of $142.92 million. 
• OSI Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSIS#NASDAQ">OSIS</a>) is expected to report quarterly earnings at $2.33 per share on revenue of $406.61 million. 
• Union Pacific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>) is expected to report quarterly earnings at $2.78 per share on revenue of $6.15 billion. 
• Texas Capital Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCBI#NASDAQ">TCBI</a>) is projected to report quarterly earnings at $1.08 per share on revenue of $283.78 million. 
• Old Republic Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORI#NYSE">ORI</a>) is projected to report quarterly earnings at $0.69 per share on revenue of $2.11 billion. 
• West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTBA#NASDAQ">WTBA</a>) is expected to report quarterly earnings at $0.40 per share on revenue of $21.42 million. 
• Valley Ntl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLY#NASDAQ">VLY</a>) is estimated to report quarterly earnings at $0.14 per share on revenue of $467.97 million. 
• MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) is projected to report quarterly loss at $0.18 per share on revenue of $485.52 million. 
• First BanCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBP#NYSE">FBP</a>) is likely to report quarterly earnings at $0.41 per share on revenue of $236.55 million. 
• Novagold Resources (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/NG#AMEX">NG</a>) is estimated to report earnings for its fourth quarter. 
• Northern Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRS#NASDAQ">NTRS</a>) is estimated to report quarterly earnings at $2.00 per share on revenue of $1.93 billion. 
• Dr Reddy's Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDY#NYSE">RDY</a>) is estimated to report quarterly earnings at $0.19 per share on revenue of $964.48 million. 
• Amalgamated Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAL#NASDAQ">AMAL</a>) is estimated to report quarterly earnings at $0.87 per share on revenue of $81.90 million. 
• MakeMyTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMYT#NASDAQ">MMYT</a>) is likely to report quarterly earnings at $0.45 per share on revenue of $264.99 million. 
• Heritage Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HFWA#NASDAQ">HFWA</a>) is expected to report quarterly earnings at $0.44 per share on revenue of $60.71 million. 
• Dime Community Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCOM#NASDAQ">DCOM</a>) is likely to report quarterly earnings at $0.45 per share on revenue of $62.64 million. 
• McCormick &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) is expected to report quarterly earnings at $0.77 per share on revenue of $1.77 billion. 
• American Airlines Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) is projected to report quarterly earnings at $0.39 per share on revenue of $13.13 billion. 
• TAL Education (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>) is expected to report quarterly earnings at $0.06 per share on revenue of $539.86 million. 
• Global X Guru Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GURU#NYSE">GURU</a>) is projected to report quarterly loss at $0.09 per share on revenue of $7.55 million. 
• LSI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYTS#NASDAQ">LYTS</a>) is estimated to report quarterly earnings at $0.20 per share on revenue of $129.20 million. 
• GATX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GATX#NYSE">GATX</a>) is likely to report quarterly earnings at $1.78 per share on revenue of $399.00 million. 
• Independent Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBCP#NASDAQ">IBCP</a>) is estimated to report quarterly earnings at $0.76 per share on revenue of $48.94 million. 
• Freeport-McMoRan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>) is projected to report quarterly earnings at $0.35 per share on revenue of $6.27 billion. 
• Banc of California (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BANC#NYSE">BANC</a>) is expected to report quarterly earnings at $0.23 per share on revenue of $272.18 million. 
• GE Aero (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) is likely to report quarterly earnings at $1.05 per share on revenue of $9.84 billion. 
• Atlantic Union Bankshares (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AUB#NYSE">AUB</a>) is estimated to report quarterly earnings at $0.79 per share on revenue of $222.26 million. 
<h3>Companies Reporting After The Bell</h3>
• Texas Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>) is projected to report quarterly earnings at $1.20 per share on revenue of $3.87 billion. 
• Covenant Logistics Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVLG#NYSE">CVLG</a>) is expected to report quarterly earnings at $0.50 per share on revenue of $284.91 million. 
• OceanFirst Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCFC#NASDAQ">OCFC</a>) is projected to report quarterly earnings at $0.36 per share on revenue of $94.95 million. 
• First Western Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYFW#NASDAQ">MYFW</a>) is expected to report quarterly earnings at $0.26 per share on revenue of $24.41 million. 
• SouthState (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSB#NYSE">SSB</a>) is expected to report quarterly earnings at $1.73 per share on revenue of $434.57 million. 
• Five Point Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FPH#NYSE">FPH</a>) is likely to report earnings for its fourth quarter. 
• USCB Financial Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USCB#NASDAQ">USCB</a>) is expected to report quarterly earnings at $0.37 per share on revenue of $22.41 million. 
• First Financial Bancor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFBC#NASDAQ">FFBC</a>) is projected to report quarterly earnings at $0.65 per share on revenue of $216.32 million. 
• First Bank (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRBA#NASDAQ">FRBA</a>) is estimated to report quarterly earnings at $0.39 per share on revenue of $32.84 million. 
• SLM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLM#NASDAQ">SLM</a>) is expected to report quarterly earnings at $0.56 per share on revenue of $371.74 million. 
• MidWestOne Financial Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOFG#NASDAQ">MOFG</a>) is estimated to report quarterly earnings at $0.72 per share on revenue of $57.00 million. 
• Midland States Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSBI#NASDAQ">MSBI</a>) is likely to report quarterly earnings at $0.67 per share on revenue of $73.57 million. 
• Metropolitan Bank Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCB#NYSE">MCB</a>) is estimated to report quarterly earnings at $1.49 per share on revenue of $67.43 million. 
• Customers Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBI#NYSE">CUBI</a>) is estimated to report quarterly earnings at $1.20 per share on revenue of $164.07 million. 
• East West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) is expected to report quarterly earnings at $2.12 per share on revenue of $659.00 million. 
• Intuitive Surgical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISRG#NASDAQ">ISRG</a>) is estimated to report quarterly earnings at $1.75 per share on revenue of $2.20 billion. 
• Glacier Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GBCI#NYSE">GBCI</a>) is projected to report quarterly earnings at $0.52 per share on revenue of $224.99 million. 
• Business First Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BFST#NASDAQ">BFST</a>) is likely to report quarterly earnings at $0.49 per share on revenue of $75.13 million. 
• SB Finl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFG#NASDAQ">SBFG</a>) is expected to report quarterly earnings at $0.41 per share on revenue of $10.20 million. 
• Byline Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BY#NYSE">BY</a>) is projected to report quarterly earnings at $0.61 per share on revenue of $100.39 million. 
• Eastern Bankshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EBC#NASDAQ">EBC</a>) is projected to report quarterly earnings at $0.34 per share on revenue of $184.71 million. 
• 1st Source (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRCE#NASDAQ">SRCE</a>) is likely to report quarterly earnings at $1.33 per share on revenue of $97.65 million. 
• Associated Banc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASB#NYSE">ASB</a>) is likely to report quarterly earnings at $0.52 per share on revenue of $337.81 million. 
• Columbia Banking System (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COLB#NASDAQ">COLB</a>) is projected to report quarterly earnings at $0.66 per share on revenue of $489.74 million. 
• CSX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSX#NASDAQ">CSX</a>) is likely to report quarterly earnings at $0.44 per share on revenue of $3.61 billion. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMAL

BANC

BFST

COLB

CUBI

CVLG

DCOM

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

EWBC

FFBC

FRBA

GATX

GBCI

GURU

HFWA

IBCP

ISRG

LYTS

MMYT

MOFG

MSBI

MYFW

NTRS

OCFC

OSIS

PPBI

SBFG

SRCE

TCBI

USCB

WTBA

Earnings Scheduled For January 23, 2025

2025 Guidance
For 2025, the Company expects its total revenue to increase by NT$ 2.71~NT$3.71 billion, or 1.2%~1.6%, to NT$232.74~NT$233.74 billion as compared to the un-audited consolidated total revenue of 2024. Operating costs and expenses for 2025 are expected to increase by NT$4.31~NT$4.38 billion, or 2.4%, to NT$187.58~NT$187.65 billion as compared to the prior year. Income from operations is expected to decrease by NT$0.16~NT$1.58 billion, or-0.3%~3.4% to NT$45.30~NT$46.72 billion as compared to the prior year. Income before income tax, net income attributable to stockholders of the parent and earnings per share are expected to be NT$46.11~NT$47.88 billion, NT$35.84~NT$37.39 billion and NT$4.62~NT$4.82, respectively, representing a decrease of NT$1.65 to an increase of NT$0.12 billion, a decrease of NT$1.37 to an increase of NT$ 0.18 billion and a decrease of NT$0.18 to an increase NT$0.02 respectively, year over year.
Acquisition of Property, Plant and Equipment in 2025 is expected to increase by NT$3.37 billion to NT$32.36 billion as compared to the prior year, owing to the expansion of AI internet data center, new construction of submarine cable, the investments in 5G deployment to maintain a competitive edge, enhance the network resilience and security, and the elimination of energy-intensive equipment to realize ESG practices.
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">(NT$ billion except EPS)</td>
<td colspan="1" rowspan="1">2025(F)</td>
<td colspan="1" rowspan="1">
2024
(un-audited)
</td>
<td colspan="1" rowspan="1">&nbsp;change</td>
<td colspan="1" rowspan="1">YoY(%)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Revenue</td>
<td colspan="1" rowspan="1">232.74~233.74</td>
<td colspan="1" rowspan="1">230.03</td>
<td colspan="1" rowspan="1">2.71~3.71</td>
<td colspan="1" rowspan="1">1.2%~1.6%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Operating Costs and Expenses</td>
<td colspan="1" rowspan="1">187.58~187.65</td>
<td colspan="1" rowspan="1">183.27</td>
<td colspan="1" rowspan="1">4.31~4.38</td>
<td colspan="1" rowspan="1">2.4&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Other Income and Expense</td>
<td colspan="1" rowspan="1">0.13~0.63</td>
<td colspan="1" rowspan="1">0.12</td>
<td colspan="1" rowspan="1">0.01~0.51</td>
<td colspan="1" rowspan="1">8.6%~419.0%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Income from Operations</td>
<td colspan="1" rowspan="1">45.30~46.72</td>
<td colspan="1" rowspan="1">46.88</td>
<td colspan="1" rowspan="1">(1.58)~(0.16)</td>
<td colspan="1" rowspan="1">(3.4%)~(0.3%)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Non-operating Income</td>
<td colspan="1" rowspan="1">0.81~1.16</td>
<td colspan="1" rowspan="1">0.88</td>
<td colspan="1" rowspan="1">(0.07)~0.28</td>
<td colspan="1" rowspan="1">(8.0%)~31.8%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Income before Income Tax</td>
<td colspan="1" rowspan="1">46.11~47.88</td>
<td colspan="1" rowspan="1">47.76</td>
<td colspan="1" rowspan="1">(1.65)~0.12</td>
<td colspan="1" rowspan="1">(3.5%)~0.3%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net Income Attributable to Stockholders of The Parent</td>
<td colspan="1" rowspan="1">35.84~37.39</td>
<td colspan="1" rowspan="1">37.21</td>
<td colspan="1" rowspan="1">(1.37)~0.18</td>
<td colspan="1" rowspan="1">(3.7%)~0.5%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">EPS(NT$)</td>
<td colspan="1" rowspan="1">4.62~4.82</td>
<td colspan="1" rowspan="1">4.80</td>
<td colspan="1" rowspan="1">(0.18)~0.02</td>
<td colspan="1" rowspan="1">(3.8%)~0.4%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">EBITDA</td>
<td colspan="1" rowspan="1">86.04~87.46</td>
<td colspan="1" rowspan="1">86.50</td>
<td colspan="1" rowspan="1">(0.46)~0.96</td>
<td colspan="1" rowspan="1">(0.5%)~1.1%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">EBITDA Margin</td>
<td colspan="1" rowspan="1">37.0%~37.4%</td>
<td colspan="1" rowspan="1">37.6&nbsp;%</td>
<td colspan="1" rowspan="1">(0.6%)~(0.2%)</td>
<td colspan="1" rowspan="1"> &nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Acquisition of Material Assets</td>
<td colspan="1" rowspan="1">35.37</td>
<td colspan="1" rowspan="1">30.24</td>
<td colspan="1" rowspan="1">5.13</td>
<td colspan="1" rowspan="1">17.0&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Acquisition of Property,&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Plant and Equipment and &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Intangible Assets</td>
<td colspan="1" rowspan="1">32.36</td>
<td colspan="1" rowspan="1">28.99</td>
<td colspan="1" rowspan="1">3.37</td>
<td colspan="1" rowspan="1">11.6&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Others</td>
<td colspan="1" rowspan="1">3.01</td>
<td colspan="1" rowspan="1">1.25</td>
<td colspan="1" rowspan="1">1.76</td>
<td colspan="1" rowspan="1">140.8&nbsp;%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Disposal of Material Assets</td>
<td colspan="1" rowspan="1">-</td>
<td colspan="1" rowspan="1">0.02</td>
<td colspan="1" rowspan="1">(0.02)</td>
<td colspan="1" rowspan="1">(100&nbsp;%)</td>
</tr>
</tbody>
</table>
</figure>

Chunghwa Telecom Expects FY25 Revenue Growth Of 1.2%-1.6% YoY Vs $6.79B Est, EPS Growth Of (3.8%)~0.4% YoY Vs $1.47 Est

Nidec (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NJDCY#OTC">NJDCY</a>) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.07 by 20 percent. This is a 40 percent increase over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $4.278 billion which missed the analyst consensus estimate of $4.480 billion by 4.51 percent. This is a 6.39 percent increase over sales of $4.021 billion the same period last year.

Earnings Misses

NJDCY

Nidec Q3 2024 GAAP EPS $0.08 Beats $0.07 Estimate, Sales $4.278B Miss $4.480B Estimate

Billionaire Elon Musk-led Department of Government Efficiency has set its sights on an unexpected target: the U.S. penny, highlighting the coin&#8217;s staggering production costs that <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43095721/dogecoin-up-2-after-logo-appears-on-doge-department-site">exceed its face value</a>.
What Happened: In a recent X post, DOGE revealed that pennies cost over 3 cents to manufacture, resulting in $179 million in taxpayer expenses during fiscal year 2023. The U.S. Mint produced 4.5 billion pennies last year, representing approximately 40% of total coin circulation.
Current production costs render each penny economically inefficient. The coin&#8217;s composition — 97.5% zinc and 2.5% copper plating — costs more to create than its one-cent value. The U.S. Mint&#8217;s latest reports confirm the penny&#8217;s production expense at 3.07 cents per coin.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The penny costs over 3 cents to make and cost US taxpayers over $179 million in FY2023. The Mint produced over 4.5 billion pennies in FY2023, around 40% of the 11.4 billion coins for circulation produced. Penny (or 3 cents!) for your thoughts. Sources:<a href="https://t.co/Y5LlrpyA62">https://t.co/Y5LlrpyA62</a>…
&mdash; Department of Government Efficiency (@DOGE) <a href="https://twitter.com/DOGE/status/1881928086305870127?ref_src=twsrc%5Etfw">January 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/general/entertainment/25/01/43150781/netflix-crushed-q4-thanks-to-sports-squid-game-says-gary-black-analyst-highlights-low-attrition-despite-price-hikes-predicts-stock-upside">Netflix Crushed Q4 Thanks To Sports, Squid Game, Says Gary Black: Analyst Highlights Low Attrition Despite Price Hikes, Predicts Stock Upside</a>
Why It Matters: Musk&#8217;s critique arrives amid growing debates about the penny&#8217;s relevance. Economic experts have long argued that maintaining low-denomination coins creates unnecessary financial burden. Several allied nations, including Canada and the United Kingdom, have already eliminated similar low-value coins.
The penny&#8217;s production involves a complex six-step process across four U.S. Mint facilities, with parts and labor accounting for 88% of manufacturing costs. Technological advancements and potential composition changes could offer future cost-reduction strategies.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/25/01/43152468/cnn-prepares-to-lay-off-hundreds-amid-warner-bros-discoverys-digital-overhaul-and-industry-wide-shift-report">CNN Prepares To Lay Off Hundreds Amid Warner Bros. Discovery&#8217;s Digital Overhaul And Industry-Wide Shift: Report</a></li>
</ul>
Image Via Shutterstock 
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Government

Elon Musk's DOGE Takes Aim At The US Penny Citing Soaring Production Costs

McCormick &amp; Company, Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) will release its fourth-quarter financial results, before the <a href="https://www.benzinga.com/quote/MKC/earnings">opening bell, on Thursday, Jan. 23, 2025.</a>
Analysts expect the Hunt Valley, Maryland-based company to report quarterly earnings at 77 cents per share, down from 85 cents per share in the year-ago period. McCormick projects quarterly revenue of $1.77 billion, compared to $1.75 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Nov. 19, 2024, McCormick raised its quarterly dividend from 42 cents to 45 cents per share on its common stock.
McCormick shares fell 1.4% to close at $73.24 on Wednesday&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; .
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/MKC/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>JP Morgan analyst Ken Goldman maintained an Underweight rating and cut the price target from $68 to $66 on Jan. 15, 2025. This analyst has an accuracy rate of 76%.</li>
<li>TD Cowen analyst Robert Moskow upgraded the stock from Hold to Buy and raised the price target from $86 to $90 on Jan. 8, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Jefferies analyst Rob Dickerson upgraded the stock from Hold to Buy and raised the price target from $85 to $91 on Dec. 9, 2024. This analyst has an accuracy rate of 68%.</li>
<li>Argus Research analyst John Staszak upgraded the stock from Hold to Buy with a price target of $88 on April 2, 2024. This analyst has an accuracy rate of 68%.</li>
</ul>
Considering buying MKC stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="579" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23025203/image-159-1024x579.png" alt="" class="wp-image-746235" style="width:460px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23025203/image-159-1024x579.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23025203/image-159-300x170.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23025203/image-159-768x435.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23025203/image-159.png 1117w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43126364/jim-cramer-this-tech-stock-is-a-buy-amd-is-a-great-company">Jim Cramer: AMD Is A &#8216;Great&#8217; Company, Hold Onto Dow Inc.</a></li>
</ul>

Pre-Market Outlook

McCormick Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Sandvik (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SDVKY#OTC">SDVKY</a>) reported quarterly earnings of $0.30 per share. This is a 0.67 percent increase over earnings of $0.30 per share from the same period last year. The company reported $2.98 billion in sales this quarter. This is a 0.13 percent decrease over sales of $2.99 billion the same period last year.

SDVKF

SDVKY

Sandvik Q4 Adj. EPS $0.302 Up From $0.30 YoY, Sales $2.984B Down From $2.99B YoY

The CNN Money Fear and Greed index showed further improvement in overall market sentiment, while the index remained in the &#8220;Fear&#8221; zone on Wednesday.
U.S. stocks settled higher on Wednesday, with the S&amp;P 500 surging to a new all-time high during the session.
Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) reported stronger-than-expected fourth-quarter financial results on Tuesday. Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) posted better-than-expected second-quarter financial results. Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion.
On the economic data front, U.S. mortgage applications rose 0.1% from the previous week in the week ending Jan. 17.
Most sectors on the S&amp;P 500 closed on a negative note, with utilities, real estate, and energy stocks recording losses on Wednesday. However, information technology and communication services stocks bucked the overall market trend, closing the session higher.
The Dow Jones closed higher by around 131 points to 44,156.73 on Wednesday. The S&amp;P 500 rose 0.61% to 6,086.37, while the Nasdaq Composite climbed 1.28% at 20,009.34 during Wednesday's session.
Investors are awaiting earnings results from GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), American Airlines Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>), and Union Pacific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UNP#NYSE">UNP</a>) today.
What is CNN Business Fear &amp; Greed Index?
At a current reading of 43.3, the index remained in the &#8220;Fear&#8221; zone on Wednesday, versus a prior reading of 41.5.
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/01/43126364/jim-cramer-this-tech-stock-is-a-buy-amd-is-a-great-company">Jim Cramer: AMD Is A &#8216;Great&#8217; Company, Hold Onto Dow Inc.</a></li>
</ul>
Photo courtesy: Shutterstock

NFLX

S&P 500 Hits New Record As Netflix Reports Strong Results: Investor Sentiment Improves But Greed Index Remains In 'Fear' Zone

Chunghwa Telecom (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHT#NYSE">CHT</a>) reported quarterly earnings of $0.36 per share. This is a 9.09 percent increase over earnings of $0.33 per share from the same period last year. The company reported $2.02 billion in sales this quarter. This is a 3.94 percent increase over sales of $1.94 billion the same period last year.

Chunghwa Telecom Q4 EPS $0.36 Up From $0.33 YoY, Sales $2.02B Up From $1.94B YoY

Elon Musk&#8216;s <a href="https://www.benzinga.com/markets/equities/25/01/43150976/dan-ives-raises-tesla-price-target-to-550-sees-golden-era-for-elon-musk-under-trump-sees-bull-case-upside-of-over-56-if-optimus-robot-counted-in-valuation">Tesla Inc</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) could deliver a &#8220;choppy&#8221; first half given headwinds from Donald Trump&#8216;s new electric vehicle policies, uncertainties in deliveries, and automotive gross margin. However, this Piper Sandler analyst describes the EV maker as its number one &#8220;buy-and-hold idea&#8221;.
The Piper Sandler Analyst: Alexander Potter maintained his ‘overweight' rating and raised its target price to $500 from $315 apiece, representing a 20.45% increase from its current price level of $415.11, as of Wednesday&#8217;s close.
The Analyst Takeaways: According to the Piper Sandler note, Tesla&#8217;s success in the near future depends on two key things:
<ul>
<li>How many cars they sell: Tesla plans to release new vehicles soon, but the exact timing is uncertain. This makes it hard to predict how many cars they will sell in 2025, says the note. While there&#8217;s a chance they might sell fewer cars than expected, it&#8217;s unlikely to see clear evidence of this until the upcoming earnings call on Jan. 29.</li>
</ul>
<ul>
<li>How much profit they make on each car: Piper Sandler is more optimistic about Tesla&#8217;s profit margins. As long as they continue to release new products as planned, they expect their profitability to remain strong.</li>
<li></li>
</ul>
Also, the note adds that Tesla&#8217;s future success hinges on emerging technologies like Optimus robots and AI-powered services. Since valuing these uncertain revenue streams is challenging, Piper Sandler has adopted a price-to-earnings approach over a discounted cash flow approach, which measures a stock&#8217;s intrinsic value in a constant growth environment.
Piper Sandler&#8217;s $500 price target assumes a P/E of 120 for 2026 earnings.
The note added that over the next year, the analyst expects investors to gain a clearer understanding of Tesla&#8217;s new product rollout.
Why It Matters: Apart from the factors mentioned in the research note, President Trump&#8217;s <a href="https://www.benzinga.com/trading-ideas/movers/25/01/43147598/ev-stocks-are-falling-today-whats-going-on">revocation</a> of Joe Biden&#8216;s EV targets, freezing the EV infrastructure funding, and proposals of repealing tax credits, could raise concerns.
See Also: <a href="https://www.benzinga.com/25/01/43151994/tesla-to-hike-car-prices-in-canada-by-as-much-as-c9000">Tesla To Raise Prices In Canada: Model 3 Sees Up To $6,200 Hike </a>
Price Action: Tesla&#8217;s stock fell by 0.32% in after-hours trading on Wednesday. Over the past year, TSLA has experienced a notable growth of 98.48%.
The stock&#8217;s 52-week range is between $488.54 and $138.80. With a market capitalization of $1.33 trillion, TSLA's forward price-to-earnings ratio of 119.048 is higher than the industry average of 25.750 and it has a relative strength index of 52.72, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Tesla has a consensus &#8216;hold&#8217; with a price target of $308.4, according to the 34 <a href="https://www.benzinga.com/quote/TSLA/analyst-ratings">analysts tracked by Benzinga</a>. The high target is $550, and the low is $24.86. Recent ratings by Wedbush, Piper Sandler, and Barclays suggest a $458.33 target, implying a 10.77% upside.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/TSLA/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="385" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23015518/Tesla-ANR-1024x385.png" alt="" class="wp-image-746106" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23015518/Tesla-ANR-1024x385.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23015518/Tesla-ANR-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23015518/Tesla-ANR-768x289.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/01/23015518/Tesla-ANR.png 1060w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/management/25/01/43073354/warren-buffett-openly-called-bitcoin-a-rat-poison-in-2018-7-years-later-he-is-invested-in-this-crypto-linked-stock-which-soared-27-in-2024">Warren Buffett Openly Called Bitcoin A &#8216;Rat Poison&#8217; In 2018. 7 Years Later, He Is Invested In This Crypto-Linked Stock Which Soared 27% In 2024 </a></li>
</ul>

Analyst Color

Long Ideas

Market Summary

Reiteration

Tesla Set For A 'Choppy' First Half Amid New EV Policies, But This Analyst Sees 20% Upside For Elon Musk's EV Company With A $500 Price Target

XITK: Unconvincing Risk/Benefit Profile

Stock Picks From Seeking Alpha's December 2024 New Analysts

ClearBridge Growth Strategy Q4 2024 Commentary

Wells Fargo analyst Stan Berenshteyn raised the firm's price target on Doximity (DOCS) to $43 from $41 as estimates positioned for potential near-t...

Doximity price target raised to $43 from $41 at Wells Fargo

Doximity: Upgraded To Buy Amid Promising Growth And Strong Execution

The telemedicine industry is transforming healthcare with digital platforms, growing consumer demand, and innovative care delivery models. As the sector evolves, telemedicine stocks like Doximity (DOCS), Hims & Hers Health (HIMS), and GoodRx Holdings (GDRX) are well-positioned to capitalize on this trend. Read on… Telemedicine, which became a household term during the pandemic, is now a go-to option for many patients who prefer to avoid the hassle of doctor visits. Instead of driving to appointments or sitting in crowded waiting rooms, patients can easily get prescriptions and treatment recommendations and even check their vitals using connected devices from the comfort of home.
As the demand for these services keeps growing, investors could take a look at these three telemedicine stocks that are well-positioned to benefit from this trend and help make healthcare more accessible: Doximity, Inc. (<a href="https://stocknews.com/stock/DOCS/">DOCS</a>), Hims &amp; Hers Health, Inc. (<a href="https://stocknews.com/stock/HIMS/">HIMS</a>), and GoodRx Holdings, Inc. (<a href="https://stocknews.com/stock/GDRX/">GDRX</a>).
With the digitization of healthcare, telemedicine offers an efficient, scalable way to bridge care gaps and enhance patient outcomes. Online doctor consultations are projected to <a href="https://tateeda.com/blog/future-of-telemedicine">increase by 13.7 million</a> between 2024 and 2028, reflecting an increase of 11.7%. Over half of U.S. patients now find virtual visits more convenient than traditional ones.
Given the growing demand for telemedicine, the market is estimated to grow at a <a href="https://www.openpr.com/news/3808473/global-telemedicine-market-size-share-trends-growth#:~:text=The%20global%20telemedicine%20market%20size,USD%20426.90%20billion%20by%202034.">CAGR of 19.3%</a> during the forecast period of 2025-2034, reaching a value of $426.90 billion by 2034. This growth presents a promising outlook for telemedicine providers, as it is likely to drive increased consumer demand for convenient healthcare solutions, potentially boosting their revenue.
To that end, let us dig deeper into the fundamentals of the aforementioned stocks in detail:
Doximity, Inc. (<a href="https://stocknews.com/stock/DOCS/">DOCS</a>)
DOCS operates a cloud-based digital platform designed specifically for medical professionals in the United States. It serves as a hub where physicians and healthcare practitioners can connect with peers, access the latest medical research and news, conduct virtual patient visits, and streamline career management.
The stock's trailing-12-month EBIT and levered FCF margins of 39.27% and 35.67% are significantly above their respective industry averages of 2.45% and 2.13%. Likewise, its trailing-12-month gross profit margin of 89.94% is 54% higher than the industry average of 58.39%.
DOCS' revenue increased 20.4% year-over-year to $136.83 million in the fiscal 2025 second quarter, which ended on September 30, 2024. Its non-GAAP operating income came in at $74.60 million, up 41.3% year-over-year. In addition, the company's non-GAAP <a href="https://www.investopedia.com/terms/n/netincome.asp">net income</a> amounted to $61.10 million or $0.30 per share, reflecting an increase of 34% and 36.4% year-over-year, respectively.
Analysts expect DOCS' revenue for the fiscal third quarter (ended December 2024) to increase 13% year-over-year to $152.80 million. Its EPS for the same quarter is expected to grow 15.8% from the prior year to $0.34. In addition, it surpassed the consensus EPS and revenue estimates in each of the trailing four quarters, which is promising.
Shares of DOCS have gained 68.3% over the past year and 80.8% over the past six months to close the last trading session at $49.71.
DOCS' bright prospects are apparent in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. The POWR Ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree.
It has an A grade for Quality and is ranked #44 out of 62 stocks in the <a href="https://stocknews.com/category/medical-services/">Medical – Services</a> industry. <a href="https://stocknews.com/stock/DOCS/">Click here</a> to see DOCS' ratings for Growth, Value, Momentum, Stability, and Sentiment.
Hims &amp; Hers Health, Inc. (<a href="https://stocknews.com/stock/HIMS/">HIMS</a>)
HIMS is a multi-specialty telehealth company connecting consumers to licensed healthcare professionals. Its cloud-based technology enables consumers to access medical care and purchase health and wellness products and services. In addition, the company's telehealth services allow consumers to talk to medical professionals and industry experts.
On November 21, 2024, HIMS introduced daily meal replacement bars and shakes as part of its comprehensive weight loss offerings. Priced at $110 per month, these nutrient-packed supplements, developed by registered dietitians and nutritionists, are tailored to support individual weight loss goals, particularly for patients using GLP-1 medications. This new offering could drive strong demand and boost HIMS' revenue by expanding its weight loss product portfolio.
HIMS' trailing-12-month gross profit margin of 81.13% is 38.9% higher than the industry average of 58.39%. Likewise, its trailing-12-month levered FCF margin of 10.21% is 379% higher than the industry average of 2.13%.
In the fiscal third quarter, which ended on September 30, 2024, HIMS' total revenue increased by 77.1% year-over-year to $401.56 million. Its income from operations amounted to $22.37 million, compared to a loss of $8.55 million in the prior year quarter. Moreover, its net income stood at $75.59 million or $0.32 per share, compared to a loss of $7.57 million or $0.04 per share in the prior year quarter, respectively.
The consensus revenue estimate of $469.68 million for the fourth quarter (ended December 2024) represents a 90.5% improvement year-over-year. The consensus EPS estimate of $0.11 for the same period indicates a significant increase from the previous year. The company has an impressive earnings surprise history, surpassing the consensus revenue estimates in each of the trailing four quarters.
The stock has surged 202.2% over the past year to close the last trading session at $25.90. However, it has declined 13.7% over the past month.
HIMS' POWR Ratings reflect strong prospects. It has an A grade for Growth and Quality. Of the 62 stocks in the Medical – Services industry, it is ranked #34. To access HIMS' Value, Momentum, Stability, and Sentiment ratings, <a href="https://stocknews.com/stock/HIMS/">click here</a>.
GoodRx Holdings, Inc. (<a href="https://stocknews.com/stock/GDRX/">GDRX</a>)
GDRX provides a consumer-focused digital healthcare platform in the United States. The company offers consumers free access to branded and generic medications, medical provider consultations via telehealth, and comprehensive healthcare research and information.
On January 7, 2025, GDRX introduced "GoodRx for Pets," offering a convenient and cost-effective solution for pet owners to access medications. This service allows users to save up to 80% on pet prescriptions for conditions like allergies, anxiety, and diabetes, with delivery powered by Allivet and coverage at over 70,000 pharmacies nationwide. The platform's seamless e-commerce integration enhances accessibility and affordability, positioning the company to capture the growing demand for pet healthcare solutions.
The stock's trailing-12-month gross profit margin of 94.09% is 61.15% higher than the industry average of 58.39%. Likewise, its trailing-12-month EBITDA and levered FCF margins of 13.89% and 11.45% compare favorably to their respective industry average of 5.81% and 2.13%.
GDRX's revenue increased 8.5% year-over-year to $195.25 million in the fiscal third quarter that ended on September 30, 2024. Its adjusted operating income grew 17.6% from the year-ago value to $49.39 million. The company's adjusted net income came in at $31.94 million, up 25% year-over-year, while adjusted EPS rose 33.3% from the prior year's quarter to $0.08. In addition, its adjusted EBITDA amounted to $64.96 million, indicating an increase of 21.5% year-over-year.
Analysts expect GDRX's revenue for the fiscal fourth quarter (ended December 31, 2024) to increase 1.6% year-over-year to $199.73 million. Its EPS for the same quarter is expected to be $0.03. In addition, it surpassed the consensus revenue estimates in three of the trailing four quarters.
Over the past month, the stock has declined 10.4%, closing the last trading session at $4.22.
GDRX's strong fundamentals are reflected in its POWR Ratings. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system.
It has an A grade for Growth and a B for Value. Within the <a href="https://stocknews.com/category/pharmaceuticals/">Medical - Pharmaceuticals</a> industry, it is ranked #29 out of 150 stocks. <a href="https://stocknews.com/stock/GDRX/">Click here</a> to see GDRX's ratings for Momentum, Stability, Sentiment, and Quality.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
DOCS shares were trading at $50.40 per share on Tuesday afternoon, up $0.69 (+1.39%). Year-to-date, DOCS has declined -5.60%, versus a -1.15% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Shweta Kumari</h2> <img src='https:/wp-content/uploads/2022/03/Shweta-Kumari_Image-2.jpg' style="float:left; padding:5px;width:125px;">Shweta's profound interest in financial research and quantitative analysis led her to pursue a career as an investment analyst. She uses her knowledge to help retail investors make educated investment decisions.<a href="https://stocknews.com/authors/?author=shweta-kumari">More...</a>The post <a href=https://stocknews.com/news/docs-hims-gdrx-3-telemedicine-stocks-making-healthcare-more-accessible/>3 Telemedicine Stocks Making Healthcare More Accessible</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Telemedicine Stocks Making Healthcare More Accessible

The number of Americans receiving psychotherapy has increased 30% during the pandemic, but research shows the shift to teletherapy has exacerbated ...

Study shows online therapy boom mostly benefited priviledged groups, NYT says

ADSK

ALGM

AMSYF

AMWL

ARKK

AVGO

BIIB

BLDR

BRZE

CMCSA

CRWD

CYBR

DOCU

FDVV

GDRX

GINN

HIMS

HSAI

HUBS

INFR

LOUP

LRCX

LRGE

MSTLW

NIPG

NMTC

PSMMF

PSMMY

SNOW

SSNC

TALK

TDOC

TMAT

TNLIF

TNLIY

TROW

UBER

UDMY

VRTX

VSAT

XFABF

XITK

YLDE

Press Releases

DOXIMITY INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DOCS

Legal

DOXIMITY ALERT: Bragar Eagel & Squire, P.C. is Investigating Doximity, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Mendaera Closes $73M Series B Financing to Scale Robotics and AI Across Mainstream Medical Procedures

DOXIMITY INVESTOR REMINDER: Scott+Scott Attorneys at Law LLP Investigates Doximity, Inc.'s Directors and Officers for Breach of Fiduciary Duties – DOCS

Doximity to Release Fiscal 2025 Second Quarter Results on November 7, 2024

Doximity to Present at the Jefferies London Healthcare Conference

Doximity Announces Fiscal 2025 Second Quarter Financial Results

Doximity Report Confirms That Telemedicine Serves Key Role in Modern Health Care

Doximity to Release Fiscal 2025 Third Quarter Results on February 6, 2025

LVGO

Comments

Doximity

뉴스

에 대한 최신 뉴스 Doximity (NYSE:DOCS) 주식

일요일, 12월 22, 2024

월요일, 11월 11, 2024

목요일, 11월 07, 2024

금요일, 8월 09, 2024

금요일, 5월 17, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌